Homeeditorial

editorial

ChemoCentryx Announces TAVNEOS® (avacopan) Presentations at Upcoming Medical Conferences

ChemoCentryx Announces TAVNEOS® (avacopan) Presentations at Upcoming Medical Conferences

August 29, 2022

CANCER Publishes Study Demonstrating Substantial Disease Burden for Patients with Systemic Mastocytosis

CANCER Publishes Study Demonstrating Substantial Disease Burden for Patients with Systemic Mastocytosis

August 29, 2022

U.S. Government Exercises Option to Purchase Additional RAPIVAB® (peramivir injection) from BioCryst for Pandemic Influenza Preparedness

U.S. Government Exercises Option to Purchase Additional RAPIVAB® (peramivir injection) from BioCryst for Pandemic Influenza Preparedness

August 29, 2022

MAURICE icIEF ESTABLISHED AS A GREEN METHOD FOR CHARACTERIZATION OF AAV IDENTITY AND STABILITY

MAURICE icIEF ESTABLISHED AS A GREEN METHOD FOR CHARACTERIZATION OF AAV IDENTITY AND STABILITY

August 29, 2022

Ayana Bio Announces Appointment of Frank Jaksch as Chief Executive Officer

Ayana Bio Announces Appointment of Frank Jaksch as Chief Executive Officer

August 29, 2022

Grindrod Shipping Reaches a 12-Week High Following Taylor Maritime’s $365.9M Purchase Bid

Grindrod Shipping Reaches a 12-Week High Following Taylor Maritime’s $365.9M Purchase Bid

August 29, 2022

Omicron-Based Booster: Pfizer and BioNTech Seeking EU Approval

Omicron-Based Booster: Pfizer and BioNTech Seeking EU Approval

August 29, 2022

HP Shares Drop Despite Closing Poly Acquisition

HP Shares Drop Despite Closing Poly Acquisition

August 29, 2022

Lululemon’s Q2 Earnings: Factors to Watch

Lululemon’s Q2 Earnings: Factors to Watch

August 29, 2022

Catalent Falls by 10% As 4TH Quarter Results Run Lukewarm

Catalent Falls by 10% As 4TH Quarter Results Run Lukewarm

August 29, 2022

« 1 … 1,170 1,171 1,172 1,173 1,174 … 1,425 »